Authors
Loading...
Preclinical investigation reveals that IGF2BP2 exacerbates renal inflammation in lupus nephritis mouse and cell models, highlighting the IGF2BP2-STAT1 axis as a therapeutic target.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: